Institutions / STEMPOINT CAPITAL LP / Holdings
Back to STEMPOINT CAPITAL LP

Stempoint Capital LP

All holdings · as of Dec 31, 2025

75 positions

CompanyClassValueShares% of portfolio
Vistagen Therapeutics, Inc.VTGNCommon Stock$142.1K616,7490.0%
Pasithea Therapeutics Corp.KTTACommon Stock$458.1K355,0820.1%
CAPRICOR THERAPEUTICS, INC.—$515.2K17,8530.1%
VANDA PHARMACEUTICALS INC—$520.3K58,9890.1%
SAB Biotherapeutics, Inc.—$548.1K146,5580.1%
Monte Rosa Therapeutics, Inc.—$965.5K61,5770.2%
Taysha Gene Therapies, Inc.TSHACommon Stock$1.00M182,1300.2%
UNIQURE NV—$1.04M43,4850.2%
SPYRE THERAPEUTICS, INC.—$1.06M32,3770.2%
BridgeBio Oncology Therapeutics, Inc.BBOTCommon Stock$1.08M86,5170.2%
Evommune, Inc.EVMNCommon Stock$1.17M68,1960.2%
XILIO THERAPEUTICS INC—$1.30M2,030,0280.2%
BELITE BIO, INCBLTEADR$1.47M9,1630.3%
LEGEND BIOTECH CORPLEGNADR$1.59M73,3280.3%
Pharvaris N.V.—$1.62M58,3890.3%
MAPLIGHT THERAPEUTICS INCMPLTCommon Stock$1.76M100,0000.3%
ADC THERAPEUTICS SA—$1.77M502,5700.3%
AbbVie Inc.—$2.13M9,3250.4%
INVENTIVA SA—$2.17M467,2420.4%
MEIRAGTX HLDGS PLC—$2.29M287,6890.4%
Invivyd, Inc.—$2.44M989,8220.4%
Avalo Therapeutics, Inc.—$2.46M135,5520.4%
QUINCE THERAPEUTICS INC—$2.48M739,2640.4%
MBX Biosciences, Inc.MBXCommon Stock$2.48M78,5530.4%
NEWAMSTERDAM PHARMA COMPANY—$2.56M73,1060.4%
REPLIGEN CORP—$2.57M15,7070.4%
ASCENDIS PHARMA A/S—$3.16M14,8420.5%
Dianthus Therapeutics, Inc.—$3.27M79,2840.6%
Whitehawk Therapeutics, Inc.WHWKCommon Stock$3.53M1,458,8070.6%
X4 Pharmaceuticals, Inc—$3.59M898,4650.6%
CytomX Therapeutics, Inc.—$4.41M1,036,3110.8%
MoonLake ImmunotherapeuticsMLTXCommon Stock$4.59M348,4010.8%
Arbutus Biopharma CorpABUSCommon Stock$4.75M986,7510.8%
Viridian Therapeutics, Inc.—$4.80M154,3200.8%
Revolution Medicines, Inc.—$4.94M62,0320.8%
Trevi Therapeutics, Inc.—$5.00M399,5570.9%
ELI LILLY & Co—$5.11M4,7590.9%
PROTAGONIST THERAPEUTICS INC—$5.19M59,4300.9%
Maze Therapeutics, Inc.—$5.22M125,8770.9%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$5.33M156,7280.9%
IDEAYA BIOSCIENCES, INC.—$5.59M161,6591.0%
INCYTE CORP—$6.07M61,4351.0%
Apogee Therapeutics, Inc.—$6.08M80,5741.0%
Praxis Precision Medicines, Inc.—$6.21M21,0671.1%
RHYTHM PHARMACEUTICALS, INC.—$6.31M58,9151.1%
Ocular Therapeutix, Inc—$6.35M522,6931.1%
IMMATICS N.V—$6.41M610,3081.1%
EyePoint, Inc.—$6.46M353,8491.1%
Arcutis Biotherapeutics, Inc.—$6.53M224,7401.1%
ClearPoint Neuro, Inc.—$6.59M481,8581.1%
← PrevPage 1 of 2Next →